BLACK JAMES FOUNDATION innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United Kingdom	50
#2	WIPO (World Intellectual Property Organization)	26
#3	Australia	22
#4	United States	21
#5	South Africa	13
#6	EPO (European Patent Office)	12
#7	Canada	7
#8	Hungary	7
#9	Norway	7
#10	New Zealand	6
#11	Poland	5
#12	China	4
#13	Finland	4
#14	Brazil	3
#15	Ireland	2
#16	Mexico	2
#17	Singapore	2
#18	Argentina	1
#19	Czechia	1
#20	Israel	1
#21	Taiwan	1

Patent filings per year

Similar Companies

LIPHA 100% similarity

MUTABILIS SA 99% similarity

USV PHARMA CORP 99% similarity

QIAN XIANGPING 99% similarity

KEFALAS AS 99% similarity

FAB PHARMA S A S 99% similarity

MAGGIONI FARMA 99% similarity

TRIO MEDICINES LTD 99% similarity

IMMUNOMET THERAPEUTICS INC 99% similarity

THIEMANN CHEM PHARM FAB 99% similarity

Focus industries

#	Industry
#1	Organic fine chemistry
#2	Pharmaceuticals
#3	Biotechnology
#4	Environmental technology
#5	Machines

Focus technologies

#	Technology
#1	Heterocyclic compounds
#2	Therapeutic chemical compounds
#3	Medical preparations
#4	Acyclic or carbocyclic compounds
#5	Peptides
#6	Climate change mitigation in goods production
#7	Unspecified technologies

Top inventors

#	Name	Total Patents
#1	Kalindjian Sarkis Barret	117
#2	Mcdonald Iain Mair	86
#3	Low Caroline Minli Rachel	79
#4	Steel Katherine Isobel Mary	67
#5	Pether Michael John	66
#6	Buck Ildiko Maria	64
#7	Shankley Nigel Paul	54
#8	Tozer Matthew John	54
#9	Harper Elaine Anne	51
#10	Dunstone David John	50

Latest patents

Publication	Filing date	Title
GB0624214D0	2006-12-04	Benzotriazepinone derivatives
GB0614579D0	2006-07-21	Pyrimidine derivatives
GB0425196D0	2004-11-15	Gastrin and cholecystokinin receptor ligands
GB0310864D0	2003-05-12	Gastrin and cholecystokinin receptor ligands
GB0310865D0	2003-05-12	Gastrin and cholecystokinin receptor ligands
BR0213317A	2002-11-12	Use of a compound, method of treating a gastrin-related disorder, pharmaceutical composition, kit, uses of a composition, and a proton pump inhibitor, methods of preparing a pharmaceutical composition and a compound, and, compound
GB0219051D0	2002-08-15	Gastrin and cholecystokinin receptor ligands (V1-2)
GB0127262D0	2001-11-13	Gastrin and cholecystokinin receptor ligands (VI)
GB0011089D0	2000-05-08	Gastrin and cholecystokinin receptor ligands (11)
GB0011094D0	2000-05-08	Gastrin and cholecystokinin receptor ligands (III)
GB0011095D0	2000-05-08	astrin and cholecystokinin receptor ligands (III)
GB0011092D0	2000-05-08	Gastrin and cholecystokinin receptor ligands (III)
GB0011098D0	2000-05-08	Pharmaceutical compositions comprising protpn pump inhibitors and gastrin/cholecystokinin receptor ligands
US6479531B1	1999-11-09	Gastrin and cholecystokinin receptor ligands
GB9824536D0	1998-11-09	Gastrin and cholecystokinin receptor ligands
GB0000112D0	1998-07-14	1H-4(5)-substituted imidazole derivatives their preparation and their use as histamine H 3 receptor ligands
GB9803536D0	1998-02-19	Histamine H,receptor ligands
GB9715814D0	1997-07-25	Histamine H3 receptor ligands
GB9715816D0	1997-07-25	Histamine H receptor ligands
GB9817823D0	1997-03-07	Benzodiazonine derivatives binding to cholecystokinin or gastrin receptors